5 Best Growth Stocks for the Next 10 Years

Page 5 of 5

1. Chimerix, Inc. (NASDAQ:CMRX)

Trailing P/E Ratio: 0.59

Chimerix, Inc. (NASDAQ:CMRX) is a biotechnology firm that develops treatments for serious diseases such as tumors, cancer, and leukemia. The stock is rated Strong Buy on average and analysts have also penciled in a $6 share price upside. Its three year average revenue growth rate is 39.28%.

As this year’s first quarter ended, 13 of the 943 hedge funds part of Insider Monkey’s database had held a stake in the firm. Chimerix, Inc. (NASDAQ:CMRX)’s largest shareholder is David Rosen’s Rubric Capital Management with an investment of $9.2 million.

Follow Chimerix Inc (NASDAQ:CMRX)

Disclosure: None. You can also take a look at 11 High Growth Utility Stocks to Buy and 10 Best Stocks To Invest In For Financial Stability.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5